India has approved the QDENGA vaccine from Japan's Takeda Pharmaceutical, making it the first dengue vaccine to receive marketing approval in the country. The vaccine is expected to play a major role in the country's battle against dengue.
India has approved the QDENGA vaccine from Japan's Takeda Pharmaceutical, making it the first dengue vaccine to receive marketing approval in the country. The vaccine is expected to play a major role in the country's battle against dengue, which has been a major public health concern in India for many years. The approval of the QDENGA vaccine marks a significant milestone in India's fight against dengue, with many experts predicting that the vaccine will be a major game-changer in the country's efforts to control the disease.